Literature DB >> 9714592

Biclonal primary plasma cell leukemia.

Z Tóth1, J Sipos.   

Abstract

Authors present a multiparameter pathological study in a case of rapid biclonal primary plasma cell leukemia. The immunohistochemical data revealed aberrant phenotypes (monocyte, epithelial and T-cell) probably in connection with microenvironmental influences. Biclonality can be attributed to class switching during malignant transformation. Static image cytometry showed aneuploidy. The blasts of this process are active immunoregulatory cells.

Entities:  

Mesh:

Year:  1998        PMID: 9714592     DOI: 10.1007/bf02904696

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  19 in total

Review 1.  Cytogenetics and molecular genetics in multiple myeloma.

Authors:  R Feinman; J Sawyer; J Hardin; G Tricot
Journal:  Hematol Oncol Clin North Am       Date:  1997-02       Impact factor: 3.722

2.  Immunoreactive cytokeratins in plasmacytomas.

Authors:  A C Wotherspoon; A J Norton; P G Isaacson
Journal:  Histopathology       Date:  1989-02       Impact factor: 5.087

3.  Cytokeratin-positive large-cell lymphomas of B-cell lineage. A study of five phenotypically unusual cases verified by polymerase chain reaction.

Authors:  J Lasota; E Hyjek; C H Koo; J Blonski; M Miettinen
Journal:  Am J Surg Pathol       Date:  1996-03       Impact factor: 6.394

4.  Biclonal IgM gammopathy in chronic lymphocytic leukemia.

Authors:  K F Schaffner; J R Krause; R H Kelly
Journal:  Arch Pathol Lab Med       Date:  1988-02       Impact factor: 5.534

5.  A case with primary gastric lymphoma producing IgM and IgG immunoglobulins.

Authors:  Y Yatabe; N Mori; K Oka; J Asai
Journal:  Arch Pathol Lab Med       Date:  1994-06       Impact factor: 5.534

6.  Biclonal IgM gammopathy in a lymphoproliferative disorder.

Authors:  H Gerstein; D R Budman; P Schulman; V Vinciguerra; T J Degnan; M Susin
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

Review 7.  Myeloma biology and therapy. Present status and future developments.

Authors:  N Nishimoto; Y Shima; K Yoshizaki; T Kishimoto
Journal:  Hematol Oncol Clin North Am       Date:  1997-02       Impact factor: 3.722

8.  DNA aneuploidy, increased proliferation and nuclear area of plasma cells in monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  E Leo; M Kropff; A Lindemann; G Steinfurth; H Esselborn; R Rossner; C P Adler; A Böcking
Journal:  Anal Quant Cytol Histol       Date:  1995-04       Impact factor: 0.302

9.  Assessment of cell proliferation in normal and pathological bone marrow biopsies: a study using double sequential immunophenotyping on paraffin sections.

Authors:  W Pellegrini; F Facchetti; D Marocolo; L Salvi; A Capucci; A Tironi; G Rossi
Journal:  Histopathology       Date:  1995-11       Impact factor: 5.087

10.  Expression of proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in multiple myeloma.

Authors:  A Skopelitou; S Tselenis; S Theocharis; N Agnantis; A Tsenga; J Elemenoglou; M Hadjiyannakis; C Kittas
Journal:  Anticancer Res       Date:  1994 May-Jun       Impact factor: 2.480

View more
  2 in total

1.  Combined IgG4κ and IgG1λ deposition in the glomerular and tubular basement membrane accompanied by autoimmune neutropenia (AIN) and immune thrombocytopenia (ITP).

Authors:  Chiari Kojima; Kazuho Honda; Ari Shimizu; Takahito Moriyama; Hidekazu Sugiura; Mitsuyo Itabashi; Takashi Takei; Sekiko Taneda; Takashi Ehara; Kosaku Nitta
Journal:  CEN Case Rep       Date:  2015-02-26

2.  Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia.

Authors:  Michael Gentry; Mark Pettenati; Changlee S Pang
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.